Skip to main content
. Author manuscript; available in PMC: 2020 Aug 17.
Published in final edited form as: Nat Immunol. 2020 Feb 17;21(3):331–342. doi: 10.1038/s41590-020-0598-4

Extended Data Fig. 5. Combined inhibition of mitochondrial and peroxisomal FAO with increased in vivo dosage of etomoxir and thioridazine in support of figure 5.

Extended Data Fig. 5

Absolute number of live splenic NP+ GCBC (a) and naïve NP B cells (b) and MFI of 2-NBDG of GCBC after 30min 2-NBDG in vitro pulse (c) of mice at d14 post NP-CGG immunization and in vivo treatment at d9, d11 and d13 with 22 mg/kg etomoxir and 11mg/kg thioridazine or vehicle only as in Fig. 5ce. Every dot represents and individual mouse and graphs are mean +/−SEM; ns = not significant; ****p<0.0001 by unpaired, two-tailed t-test.